David E. Goel - Net Worth and Insider Trading
David E. Goel Net Worth
The estimated net worth of David E. Goel is at least $209 Million dollars as of 2024-09-20. David E. Goel is the Director of Popular Inc and owns about 1,466,177 shares of Popular Inc (BPOP) stock worth over $150 Million. David E. Goel is also the of Adaptive Biotechnologies Corp and owns about 12,310,594 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $59 Million. Details can be seen in David E. Goel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David E. Goel has not made any transactions after 2021-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David E. Goel
David E. Goel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David E. Goel owns 5 companies in total, including Adaptive Biotechnologies Corp (ADPT) , Zentalis Pharmaceuticals Inc (ZNTL) , and Popular Inc (BPOP) among others .
Click here to see the complete history of David E. Goel’s form 4 insider trades.
Insider Ownership Summary of David E. Goel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2021-03-10 | director & 10 percent owner & other: See Remarks |
| ZNTL | Zentalis Pharmaceuticals Inc | 2020-04-03 | director & 10 percent owner |
| BPOP | Popular Inc | 2012-04-27 | director |
 | | 2021-10-28 | 10 percent owner |
| | 2023-05-04 | director & 10 percent owner & other: See Remarks |
David E. Goel Latest Holdings Summary
David E. Goel currently owns a total of 2 stocks. Among these stocks, David E. Goel owns 1,466,177 shares of Popular Inc (BPOP) as of April 27, 2012, with a value of $150 Million and a weighting of 71.85%. David E. Goel also owns 12,310,594 shares of Adaptive Biotechnologies Corp (ADPT) as of March 10, 2021, with a value of $59 Million and a weighting of 28.15%.
Latest Holdings of David E. Goel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPOP | Popular Inc | 2012-04-27 | 1,466,177 | 102.24 | 149,901,936 |
| ADPT | Adaptive Biotechnologies Corp | 2021-03-10 | 12,310,594 | 4.77 | 58,721,533 |
Holding Weightings of David E. Goel
David E. Goel Form 4 Trading Tracker
According to the SEC Form 4 filings, David E. Goel has made a total of 0 transactions in Popular Inc (BPOP) over the past 5 years. The most-recent trade in Popular Inc is the sale of 0 shares on April 27, 2012, which brought David E. Goel around $0.
According to the SEC Form 4 filings, David E. Goel has made a total of 2 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 806,000 shares on March 10, 2021, which brought David E. Goel around $32 Million.
Insider Trading History of David E. Goel
- 1
David E. Goel Trading Performance
David E. Goel Ownership Network
David E. Goel Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
David E. Goel is the director & 10 percent owner & other: See Remarks of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, David E. Goel made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 473,198 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 473,198 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
David E. Goel Mailing Address
Above is the net worth, insider trading, and ownership report for David E. Goel. You might contact David E. Goel via mailing address: C/o Matrix Capital Management Co., Lp, 1000 Winter Street, Suite 4500, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
